阿昔洛韦
參考文獻

1 2 3  . Drugs.com.   [2015-09-06]. （原始内容存档于2015-09-23）.
1 2 3 4  . Medscape Reference. WebMD.   [2014-02-05]. （原始内容存档于2014-02-19）.
↑  Kevin ES. . Kevin.   [2017-05-25]. （原始内容存档于2024-02-22） （德语）.
↑  . 术语在线(全国科学技术名词审定委员会 ).   [2024-06-22]. （原始内容存档于2024-06-22）.
1 2  de Clercq E, Field HJ. . British Journal of Pharmacology 147 (1) (Wiley-Blackwell). 2005-10-05: 1–11 (January 2006). PMC 1615839 . PMID 16284630. doi:10.1038/sj.bjp.0706446.  请检查|publication-date=中的日期值 (帮助)
1 2 3 4 5 6 7 8 9 10  . The American Society of Health-System Pharmacists.   [2015-01-01]. （原始内容存档于2015-01-05）.
↑  Rafailidis PI, Mavros MN, Kapaskelis A, Falagas ME. . Journal of Clinical Virology. November 2010, 49 (3): 151–157. PMID 20739216. doi:10.1016/j.jcv.2010.07.008.
↑  . Australian Government. 2014-03-03  [2014-04-22]. （原始内容存档于2014-04-08）.
↑  Hamilton R. . Jones & Bartlett Learning. 2015: 59. ISBN 9781284057560.
↑  . 2015-03-10  [2016-03-08]. （原始内容存档于2016-03-05）. Even with the highest maternal dosages, the dosage of acyclovir in milk is only about 1% of a typical infant dosage and would not be expected to cause any adverse effects in breastfed infants
↑  Fischer J, Ganellin CR. . John Wiley & Sons. 2006: 504  [2024-03-07]. ISBN 9783527607495. （原始内容存档于2023-01-10）.
↑  World Health Organization. . Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
↑  World Health Organization. . Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.
↑  . ClinCalc.   [2022-10-07]. （原始内容存档于2021-02-12）.
↑  . ClinCalc.   [2022-10-07]. （原始内容存档于2018-07-09）.
1 2 3 4  Rossi, S (编).  2013. Adelaide: The Australian Medicines Handbook Unit Trust. 2013. ISBN 978-0-9805790-9-3.
↑  Joint Formulary Committee.  65. London: Pharmaceutical Press. 2013. ISBN 978-0-85711-084-8.  含有內容需登入查看的頁面 (link)
↑  Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, Elting LS, Spijkervet FK, Brennan MT. . Supportive Care in Cancer. August 2010, 18 (8): 993–1006. PMID 20544224. S2CID 2969472. doi:10.1007/s00520-010-0900-3.
↑  Gershburg E, Pagano JS. . The Journal of Antimicrobial Chemotherapy. August 2005, 56 (2): 277–281. CiteSeerX 10.1.1.320.6721 . PMID 16006448. doi:10.1093/jac/dki240.
↑  De Paor M, O'Brien K, Fahey T, Smith SM. . The Cochrane Database of Systematic Reviews. December 2016, 2016 (12): CD011487. PMC 6463965 . PMID 27933614. doi:10.1002/14651858.CD011487.pub2.
↑  Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. . The Cochrane Database of Systematic Reviews. February 2014, 2014 (2): CD006866. PMC 10583132 . PMID 24500927. doi:10.1002/14651858.CD006866.pub3.
1 2  Wilhelmus KR. . The Cochrane Database of Systematic Reviews. January 2015, 1 (1): CD002898. PMC 4443501 . PMID 25879115. doi:10.1002/14651858.CD002898.pub5.
↑  Worrall G. . BMJ. January 1996, 312 (7022): 6. PMC 2349724 . PMID 8555890. doi:10.1136/bmj.312.7022.6. （原始内容存档于2007-05-15）.  – Editorial
↑  Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T. . Antimicrobial Agents and Chemotherapy. July 2002, 46 (7): 2238–2243. PMC 127288 . PMID 12069980. doi:10.1128/aac.46.7.2238-2243.2002.
↑  Mascolinli M, Kort R. . Journal of the International AIDS Society. June 2010, 13 (Suppl 1): S4. PMC 2880255 . PMID 20519025. doi:10.1186/1758-2652-13-S1-S4 .
1 2 3   (PDF). GSK. FDA. 2005. （原始内容 (PDF)存档于2017-09-08）.
↑  . Treatment Guidelines from the Medical Letter. April 2005, 3 (32): 23–32. PMID 15767977.
↑  Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. . MMWR. Recommendations and Reports. April 2009, 58 (RR-4): 1–207; quiz CE1–4  [2024-03-07]. PMID 19357635. （原始内容存档于2017-12-17）.
1 2 3 4   (PDF). TGA eBusiness Services. Ranbaxy Australia Pty Ltd. 2011-08-26  [2014-02-06]. （原始内容存档于2016-08-20）.
↑  Centers for Disease Control and Prevention.  9th. Public Health Foundation. January 2006: 171–192.
↑  Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, Eidelman AI. . Pediatrics. February 2005, 115 (2): 496–506. PMID 15687461. S2CID 5791615. doi:10.1542/peds.2004-2491 .
↑  Razonable RR. . Mayo Clinic Proceedings. October 2011, 86 (10): 1009–1026. PMC 3184032 . PMID 21964179. doi:10.4065/mcp.2011.0309.
↑  Brigden D, Rosling AE, Woods NC. . The American Journal of Medicine. July 1982, 73 (1A): 182–185. PMID 6285711. doi:10.1016/0002-9343(82)90087-0.
↑  Sawyer MH, Webb DE, Balow JE, Straus SE. . The American Journal of Medicine. June 1988, 84 (6): 1067–1071  [2024-03-07]. PMID 3376977. doi:10.1016/0002-9343(88)90313-0. （原始内容存档于2020-07-24）.
↑  Helldén A, Odar-Cederlöf I, Diener P, Barkholt L, Medin C, Svensson JO, Säwe J, Ståhle L. . Nephrology, Dialysis, Transplantation. June 2003, 18 (6): 1135–1141. PMID 12748346. doi:10.1093/ndt/gfg119 .
↑  Berry L, Venkatesan P. . Journal of Clinical Virology. December 2014, 61 (4): 608–610. PMID 25440915. doi:10.1016/j.jcv.2014.09.001.
↑  Chowdhury MA, Derar N, Hasan S, Hinch B, Ratnam S, Assaly R. . American Journal of Therapeutics. 2016, 23 (3): e941–e943. PMID 24942005. S2CID 32983100. doi:10.1097/MJT.0000000000000093.
↑  Pottage JC, Kessler HA, Goodrich JM, Chase R, Benson CA, Kapell K, Levin S. . Antimicrobial Agents and Chemotherapy. August 1986, 30 (2): 215–219. PMC 180521 . PMID 3021048. doi:10.1128/aac.30.2.215.
↑  GlaxoSmithKline. Zovirax® (acyclovir sodium) for injection prescribing information. Research Triangle Park, NC; 2003 Nov
↑  Bach MC. . The New England Journal of Medicine. February 1987, 316 (9): 547. PMID 3468354. doi:10.1056/NEJM198702263160912.
↑  Baselt RC.  8th. Foster City, CA: Biomedical Publications. 2008: 29–31. ISBN 9780962652370.
↑  . gsksource.com.   [2019-08-02]. （原始内容存档于2019-08-02）.
↑  國家教育研究院. .   [2024-03-08]. （原始内容存档于2024-03-08）.
↑  全国科学技术名词审定委员会. .   [2024-03-08]. （原始内容存档于2024-03-08）.
↑  . DailyMed. Genpharm Inc. November 2006  [2014-02-05]. （原始内容存档于2014-02-21）.
↑  . electronic Medicines Compendium. Actavis UK Ltd. 2012-08-20  [2014-02-05]. （原始内容存档于2014-02-22）.
↑  Sweetman, S (编). . . London, UK: Pharmaceutical Press. 7 August 2013  [6 February 2014]. （原始内容存档于2019-09-25）.
↑  Piret J, Boivin G. . Antimicrobial Agents and Chemotherapy. February 2011, 55 (2): 459–472. PMC 3028810 . PMID 21078929. doi:10.1128/AAC.00615-10.
↑  O'Brien JJ, Campoli-Richards DM. . Drugs. March 1989, 37 (3): 233–309. PMID 2653790. S2CID 240858022. doi:10.2165/00003495-198937030-00002 .
↑  Wagstaff AJ, Faulds D, Goa KL. . Drugs. January 1994, 47 (1): 153–205. PMID 7510619. doi:10.2165/00003495-199447010-00009 .
↑  Karmoker JR, Hasan I, Ahmed N, Saifuddin M, Reza MS. . Dhaka University Journal of Pharmaceutical Sciences. 2019, 18 (1): 1–12. doi:10.3329/dujps.v18i1.41421 .
↑  . www.medicines.org.uk.   [2024-03-07]. （原始内容存档于2022-11-20）.
↑  Garrison T. . Belmont, CA: Wadsworth Publishing Company. 1999: 471.
↑  Sepčić K. . Toxin Reviews. 2000, 19 (2): 139–160. S2CID 84041855. doi:10.1081/TXR-100100318.
↑  Laport MS, Santos OC, Muricy G. . Current Pharmaceutical Biotechnology. January 2009, 10 (1): 86–105. PMID 19149592. doi:10.2174/138920109787048625.
↑  Schaeffer HJ, Gurwara S, Vince R, Bittner S. . Journal of Medicinal Chemistry. April 1971, 14 (4): 367–369. PMID 5553754. doi:10.1021/jm00286a024.
↑  Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ. . Proceedings of the National Academy of Sciences of the United States of America. December 1977, 74 (12): 5716–5720. Bibcode:1977PNAS...74.5716E. PMC 431864 . PMID 202961. doi:10.1073/pnas.74.12.5716 .
↑  US 4146715,Schaeffer HJ,「2-Amido-9-(2-acyloxyethoxymethyl)hypoxanthines」,发行于1979-03-27,指定于Burrough Wellcome Co.
↑  Vince R. . Chemtracts. 2008, 21: 127–134.
↑  . Drugs.com. American Society of Health-System Pharmacists.   [2019-03-17]. （原始内容存档于2020-03-27）.
↑  . U.S. Food and Drug Administration (FDA). 2019-12-13  [2019-12-13]. （原始内容存档于2019-12-13）.   本文含有此來源中屬於公有领域的内容。
↑  . DailyMed. 2019-12-12  [2019-12-12]. （原始内容存档于2019-12-13）.